Impact of proning with and without inhaled pulmonary vasodilators and neuromuscular blocking agents in COVID acute respiratory distress syndrome

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

121

Figures (1-2)

Tables (1-5)

Sum=180

Publishing Process of This Article

Item

Count

Browse

Download

Sum=67

Sep 9, 2025 (publication date) through Jul 27, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Crit Care Med. Sep 9, 2025; 14(3): 101327
Published online Sep 9, 2025. doi: 10.5492/wjccm.v14.i3.101327

Table 3 Logistical and linear regression of primary outcomes adjusted for baseline Sequential Organ Failure Assessment score and age

Primary outcomes	Control vs treatment subgroup	Odds ratio (95%CI)	P value	SE
Mortality	PPV	0.82 (0.19-3.36)	0.78	-
	PPV and IVd	0.57 (0.15-2.04)	0.39	-
	PPV and NMBA	0.8 (0.07-7.28)	0.84	-
	PPV, IVd and NMBA	2.15 (0.51-9.40)	0.3	-
Venovenous extracorporeal membrane oxygenation	PPV	2.33 (0.03-22.63)	0.43	-
	PPV and IVd	1.03 (0.12-10.36)	0.98	-
	PPV and NMBA	8 (0.55-139.75)	0.13	-
	PPV, IVd and NMBA	1.04 (0.17-8.90)	0.97	-
Intensive care unit LOS	PPV	-	0.028	0.24
	PPV and IVd	-	< 0.001^a	0.23
	PPV and NMBA	-	< 0.001^a	0.38
	PPV, IVd and NMBA	-	< 0.001^a	0.24
Hospital LOS	PPV	-	0.04	0.25
	PPV and IVd	-	< 0.001^a	0.23
	PPV and NMBA	-	0.007	0.4
	PPV, IVd and NMBA	-	< 0.001^a	0.03

^aStatistically significant value (P < 0.05).

IVd: Inhaled vasodilators; LOS: Length of stay; NMBA: Neuromuscular blocking agents; PPV: Prone position ventilation.

Citation: Cabrera M, Bharil S, Chin M, Yohannes S, Clark P. Impact of proning with and without inhaled pulmonary vasodilators and neuromuscular blocking agents in COVID acute respiratory distress syndrome. World J Crit Care Med 2025; 14(3): 101327
URL: https://www.wjgnet.com/2220-3141/full/v14/i3/101327.htm
DOI: https://dx.doi.org/10.5492/wjccm.v14.i3.101327